Immunosuppressive SOX9 ‐ AS1 Resists Triple‐Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Xuan Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cellular Senescence, Wnt Signaling Pathway, SOX9 Transcription Factor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of Guangzhou Women and Children's Medical Center, Foundation of Guangzhou Health Science and Technology Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Long noncoding RNAs (lncRNAs) are involved in the regulation of triple‐negative breast cancer (TNBC) senescence, while pro‐carcinogenic lncRNAs resist senescence onset leading to the failure of therapy‐induced senescence (TIS) strategy, urgently identifying the key senescence‐related lncRNAs (SRlncRNAs). We mined seven SRlncRNAs (SOX9‐AS1, LINC01152, AC005152.3, RP11‐161 M6.2, RP5‐968 J1.1, RP11‐351 J23.1 and RP11‐666A20.3) by bioinformatics, of which SOX9‐AS1 was reported to be pro‐carcinogenic. In vitro experiments revealed the highest expression of SOX9‐AS1 in MDA‐MD‐231 cells. SOX9‐AS1 knockdown inhibited cell growth (proliferation, cycle and apoptosis) and malignant phenotypes (migration and invasion), while SOX9‐AS1 overexpression rescued these effects. Additionally, SOX9‐AS1 knockdown facilitated tamoxifen‐induced cellular senescence and the transcription of senescence‐associated secretory phenotype (SASP) factors (IL‐1α, IL‐1β, IL‐6 and IL‐8) mechanistically by resisting senescence‐induced Wnt signal (GSK‐3β/β‐catenin) activation. Immune infiltration analysis revealed that low SOX9‐AS1 expression was accompanied by a high infiltration of naïve B cells, CD8 + T cells and γδ T cells. In conclusion, SOX9‐AS1 resists TNBC senescence via regulating the Wnt signalling pathway and inhibits immune infiltration. Targeted inhibition of SOX9‐AS1 enhances SASP and thus mobilises immune infiltration to adjunct TIS strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, PR China.
- Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, PR China.
ORCID-Profile: Jie Li
Förderung
- Foundation of Guangzhou Women and Children's Medical Center
- Foundation of Guangzhou Health Science and Technology Project
- National Natural Science Foundation of China
Zitieren
APA
Ye, X., Cen, Y., Li, Q., Zhang, Y. P., Li, Q., & Li, J. (2024). Immunosuppressive SOX9 ‐ AS1 Resists Triple‐Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70208
Vancouver
Ye X, Cen Y, Li Q, Zhang YP, Li Q, Li J. Immunosuppressive SOX9 ‐ AS1 Resists Triple‐Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70208
BibTeX
@article{Ye2024,
author = {Ye, Xuan and Cen, Yi and Li, Quan and Zhang, Yuan-Ping and Li, Qian and Li, Jie},
title = {Immunosuppressive SOX9 ‐ AS1 Resists Triple‐Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70208}
}
EUVIMED